Nemer also demonstrated that mitochondrial dysfunction was one of the earliest events in Ang II-induced cardiac failure, and mitochondrial dysfunction may provide new therapeutic opportunities for preventing the transition from compensated hypertrophy to heart failure [35]. This evidence concerns the gene AGT and heart failure.